Third COVID-19 vaccine in India? Expert Panel to decide on Russia’s Sputnik V

New Delhi: With a manufacturing capacity of 850 million doses in India, Sputnik V, if approved, will prove to be a big shot in the arm in the fight against coronaviruses of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia’s Sputnik V. Obtain for Emergency Use Authority (EUA) in India.

With a manufacturing capacity of 850 million doses in India, Sputnik V, if approved, will prove to be a big shot in the arm against Coronavirus

India may receive a third COVID-19 vaccine soon to consider the Sputnik V application for the Emergency Use Authority (EUA) in India as the Subject Expert Committee (SEC) will meet on Monday 12 April.

As more and more states lack a dose of the coronovirus vaccine, the center has pressed the accelerator to increase the vaccine by leaps and bounds.

Add a Comment

Your email address will not be published.